| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |